Prostate cancer study looks at hormone therapy, androgen suppression
September 23, 2013 (CHICAGO) (WLS) -- Prostate cancer patients may do just fine with fewer weeks of hormone therapy before they begin radiation treatment. Also, a new study finds cutting back on androgen suppression treatment also reduces difficult side effects.
Researchers studied more than 14,000 intermediate risk prostate cancer patients for an average of nine years. The men were divided into two groups.
One group received eight weeks of hormone therapy before beginning radiation and the second group received 28 weeks of the treatment.
Researchers at the Mayo Clinic say overall both groups had a similar survival rate after they received eight weeks of radiation. But those patients who received the longer course of hormone therapy had more side effects including hot flashes and erectile dysfunction.
The study is being presented today at the American Society for Radiation Oncology (ASTRO) 55th Annual Meeting which is being held in Atlanta.
- CPD officer killed in crash after police chase
- Brief warm-up followed by snow
- Missing plane may have created seismic event, Chinese researchers say
- ABC7 First Alert Weather Forecast
- Pi Day celebrated on 3.14 with Chicago specials 16 min ago
- Photos: Chicago police officer killed in crash
- SUV rolls off Jane Addams exit ramp in Rosemont
- Northwestern University unveils $3.75B campaign
- Rat problem could increase with spring thaw
- GOP gubernatorial candidates hold last forum before primary
- MS Awareness Month events in Chicago area
- Catalytic converters stolen from cars in Chicago Lawn
- Runway reopens after failed takeoff at PHL
- abcnews: Cracked Dam Leads to Human Remains
- 7 in 77
- John Hancock observatory to Tilt
35 min ago